United Kingdom · Question · Written question
UIN 4747
Gender Dysphoria: Prescriptions
Original
Introduced
17 January 2020
Last action
29 January 2020 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
29 January 2020
Summary
To ask the Secretary of State for Health and Social Care, if he will instruct Clinical Commissioning Groups to fund the cost of prescribing products related to gender identity for transgender and non-binary patients to ensure compliance with the Equalitie
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
17 January 2020
Written question
To ask the Secretary of State for Health and Social Care, if he will instruct Clinical Commissioning Groups to fund the cost of prescribing products related to gender identity for transgender and non-binary patients to ensure compliance with the Equalitie
Source: Commons
29 January 2020
Answer
The Department is aware of some general practitioners who have declined to accept prescribing responsibility, but we are not aware of any clinical commissioning groups refusing to fund the drugs.All National Health Service organisations are expected to co...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2020-01-17/4747
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1171587
- uk · wq-1171587 · source updated 29 January 2020